Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts

Sabine Hergovits1, Christine Mais1, Claude Haan2

  • 1Medical Clinic and Policlinic II, Division of Hepatology, University Hospital Würzburg, Würzburg, Germany.

Insights

Oncostatin M (OSM) induces antiviral genes RIG-I-like receptors (RLR) in fibroblasts via STAT1 signaling. This pathway enhances cellular antiviral defense and cooperates with interferons, suggesting a role in virus protection.

Area of Science:

  • Immunology
  • Virology
  • Cellular Biology

Background:

  • Interleukin-6 (IL)-6-type cytokines modulate immune responses but lack direct antiviral activity.
  • Oncostatin M (OSM), an IL-6 family member, induces interferon-stimulated genes (ISGs), primarily involved in antigen presentation.
  • The induction of retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) by OSM has not been previously investigated.

Purpose of the Study:

  • To investigate the capability of Oncostatin M (OSM) to induce retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) in primary fibroblasts.
  • To elucidate the signaling pathways and regulatory mechanisms involved in OSM-mediated RLR induction.
  • To assess the functional implications of OSM-induced RLR expression in cellular antiviral defense.

Main Methods:

  • Primary human fibroblasts were treated with OSM to assess gene expression.
  • Western blotting and gene knockdown techniques were used to analyze signaling pathways, including STAT1, STAT3, and SOCS3.
  • Synergistic effects of OSM with interferon-gamma (IFN-γ) on RLR transcription were evaluated.
  • The impact of OSM pre-treatment on type I interferon production upon double-stranded RNA stimulation was assessed.

Main Results:

  • OSM induced the expression of RIG-I-like receptors (RLRs), including RIG-I and MDA5, and transcription factors IRF1, IRF7, and IRF9 in primary fibroblasts.
  • The induction of these genes was dependent on both tyrosine and serine phosphorylation of STAT1.
  • STAT3-dependent SOCS3 induction counter-regulated OSM-induced STAT1 phosphorylation, with STAT3 and SOCS3 knockdown enhancing RLR and IRF expression.
  • OSM and IFN-γ synergistically mediated RLR transcription, and OSM pre-treatment enhanced type I interferon production in response to double-stranded RNA.

Conclusions:

  • OSM induces RLR expression in fibroblasts through JAK/STAT1 signaling, contributing to cellular antiviral defense.
  • STAT3-dependent SOCS3 acts as a key negative regulator of this OSM-induced pathway.
  • OSM-induced signaling cooperates with interferons to enhance RLR expression, suggesting a role in non-professional immune cells' virus protection.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K